← back to search

Margaux Fresnais

Heidelberg University · DE
Area of research
Spectroscopy · Paleontology
Research interest
Research interests include Mass Spectrometry Techniques and Applications, Analytical Chemistry and Chromatography, Advanced Proteomics Techniques and Applications, and Archaeology and ancient environmental studies.
h-index
15
citations
911
works
37
NIH funding
primary concept
email

Recent publications

Important Requirements for Desorption/Ionization Mass Spectrometric Measurements of Temozolomide-Induced 2′-Deoxyguanosine Methylations in DNA
Cancers 2023cited by 2position: firstdoi
Therapeutic drug monitoring of osimertinib in non‐small cell lung cancer and short bowel syndrome: A case report
British Journal of Clinical Pharmacology 2023cited by 1position: middledoi
Analytical Performance Evaluation of New DESI Enhancements for Targeted Drug Quantification in Tissue Sections
Pharmaceuticals 2022cited by 15position: firstdoi
Important Requirements for the Selection of Internal Standards during the Development of Desorption/Ionization Assays for Drug Quantification in Biological Matrices—A Practical Example
Molecules 2022cited by 2position: firstdoi
Rapid MALDI-MS Assays for Drug Quantification in Biological Matrices: Lessons Learned, New Developments, and Future Perspectives
Molecules 2021cited by 15position: firstdoi
Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy
Cancers 2020cited by 503position: middledoi
Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma
Cancers 2020cited by 24position: middledoi
Approaching sites of action of drugs in clinical pharmacology: New analytical options and their challenges
British Journal of Clinical Pharmacology 2020cited by 18position: middledoi
Rapid and Sensitive Quantification of Osimertinib in Human Plasma Using a Fully Validated MALDI–IM–MS/MS Assay
Cancers 2020cited by 16position: firstdoi
Rapid and Sensitive Drug Quantification in Tissue Sections Using Matrix Assisted Laser Desorption Ionization-Ion Mobility-Mass Spectrometry Profiling
Journal of the American Society for Mass Spectrometry 2020cited by 15position: firstdoi
Development and Validation of an LC–MS-Based Quantification Assay for New Therapeutic Antibodies: Application to a Novel Therapy against Herpes Simplex Virus
ACS Omega 2020cited by 15position: firstdoi
Microproteomics and Immunohistochemistry Reveal Differences in Aldo‐Keto Reductase Family 1 Member C3 in Tissue Specimens of Ulcerative Colitis and Crohn's Disease
PROTEOMICS - CLINICAL APPLICATIONS 2020cited by 13position: middledoi
An Ultrasensitive UPLC–MS/MS Assay for the Quantification of the Therapeutic Peptide Liraglutide in Plasma to Assess the Oral and Nasal Bioavailability in Beagle Dogs
Bioanalysis 2019cited by 16position: middledoi
Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor
International Journal of Molecular Sciences 2019cited by 14position: middledoi
Rapid drug detection in whole blood droplets using a desorption electrospray ionization static profiling approach – a proof‐of‐concept
Rapid Communications in Mass Spectrometry 2019cited by 13position: firstdoi
Advances in Clinical Pharmacology: Rapid Detection of Small Molecules in Solid Samples at Atmospheric Pressure Using Desorption Electrospray Ionization
OMICS A Journal of Integrative Biology 2019cited by 4position: firstdoi
Combined Immunohistochemistry after Mass Spectrometry Imaging for Superior Spatial Information
PROTEOMICS - CLINICAL APPLICATIONS 2018cited by 25position: middledoi
Digital PCR After MALDI–Mass Spectrometry Imaging to Combine Proteomic Mapping and Identification of Activating Mutations in Pulmonary Adenocarcinoma
PROTEOMICS - CLINICAL APPLICATIONS 2018cited by 21position: middledoi
Identification of MALDI Imaging Proteolytic Peptides Using LC‐MS/MS‐Based Biomarker Discovery Data: A Proof of Concept
PROTEOMICS - CLINICAL APPLICATIONS 2018cited by 21position: middledoi
In MALDI–Mass Spectrometry Imaging on Formalin‐Fixed Paraffin‐Embedded Tissue Specimen Section Thickness Significantly Influences <i>m/z</i> Peak Intensity
PROTEOMICS - CLINICAL APPLICATIONS 2018cited by 21position: middledoi
Microproteomic Profiling of High‐Grade Squamous Intraepithelial Lesion of the Cervix: Insight into Biological Mechanisms of Dysplasia and New Potential Diagnostic Markers
PROTEOMICS - CLINICAL APPLICATIONS 2018cited by 15position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Rémi Longuespée · Institut National des Sciences Appliquées de Strasbourg18 papers (2018–2023)Jürgen Burhenne · Columbus Oncology and Hematology Associates14 papers (2019–2023)Walter E. Haefeli · Chirurgische Universitätsklinik Heidelberg12 papers (2019–2023)Daniel Kazdal · Heidelberg University6 papers (2018–2023)Mark Kriegsmann · Zentrum für Pathologie und Zytodiagnostik6 papers (2018–2020) · 6 papers (2018–2020)Jörg Kriegsmann · Charité - Universitätsmedizin Berlin5 papers (2018–2020)Katharina Kriegsmann · German Center for Lung Research5 papers (2018–2020)Stefan M. Pfister · Université du Québec5 papers (2020–2022)Kristina Schwamborn · Technical University of Munich4 papers (2018–2018)Julia Benzel · German Cancer Research Center4 papers (2020–2022)Peter Schirmacher · Kliniken Essen-Mitte3 papers (2018–2018)Kristian W. Pajtler · German Cancer Research Center3 papers (2021–2022)Wilko Weichert · German Cancer Research Center3 papers (2018–2018)Christiane Zgorzelski · University Hospital Heidelberg3 papers (2018–2018)Albrecht Stenzinger · Chirurgische Universitätsklinik Heidelberg3 papers (2018–2023)Nadine Lehmann · Johannes Gutenberg University Mainz2 papers (2019–2020)Nora Backes · Johannes Gutenberg University Mainz2 papers (2019–2020)Marie A. Neu · Johannes Gutenberg University Mainz2 papers (2019–2020)Marius Majewsky · University Hospital Heidelberg2 papers (2019–2020)